Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2019 Nov 5;12:9115. doi: 10.2147/OTT.S232123

Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]

PMCID: PMC6842899  PMID: 31806996

Tang X, Liu S, Liu Y, et al. Onco Targets Ther. 2019;12:7699–7711.

Upon reviewing the article, the authors noticed an error in Figure 1A (page 7703). The authors had mixed up and uploaded the incorrect figure panel. The authors apologize for this error. The authors confirm that the revised figure does not affect the results and conclusion of the article. The corrected version of Figure 1A is as follows:

Figure 1.

Figure 1

Characterization of exosomes derived from serum. TEM showed exosomes derived from serum had round-shaped morphology ranged from 30 nm to 100 nm (A, scale bar =200 nm). Size distribution of exosomes through NTA revealed that average size of exosomes was 100 nm (B). Western blotting for CD63, TSG101, Hsp-70, Hsp-90 as exosomal markers (C).

Abbreviations: TEM, transmission electron microscopy; NTA, nanoparticle tracking analysis.


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES